Vascular Pharmaceuticals

Make payments with PayPal - it's fast, free and secure! Learn about supporting IT History Society
  • 2005

Company Description

Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy.

ounded in 2005 based on research developed in the lab of Dr. David R. Clemmons at the University of North Carolina School of Medicine, our focus is on the development of our pre-clinical product candidate, VPI-2690B, for the treatment of diabetic nephropathy. VPI anticipates filing an IND in the second half of 2013 and initiating human clinical trials by the end of the year.

CrunchBase
Edit this page
Add a company to our database